NEW YORK (GenomeWeb) – CareDx announced after the close of the market on Thursday that it has sold approximately 592,000 units in a private placement for aggregate proceeds of about $22.1 million, $8 million of which will be reserved for future investment by certain shareholders.

The units — which each consist of one share of common stock, five shares of mandatorily convertible preferred stock, and warrants to purchase three shares of common stock — were sold to selected institutional and accredited investors, including new and current shareholders. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.